Toxicogenomic Characterization of Perfluorooctanoic Acid–Associated Bladder Carcinogenesis
Cell Biology and Toxicology · 2026
DOI: 10.1007/s10565-026-10164-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Biology and Toxicology, 2026. Verfasst von Yang Liu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Yantian District People's Hospital, Shenzhen, China. Hauptthemen laut MEDLINE: Caprylates, Urinary Bladder Neoplasms, Fluorocarbons, Toxicogenetics. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: the Medical and Health Science and Technology Program of Yantian District, Shenzhen, the National Natural Science Foundation of China.
Abstract (Originalsprache)
OBJECTIVE: This study aims to bridge toxicological target prediction and bladder cancer transcriptomics by systematically identifying molecular signatures and pathways that converge between PFOA-associated toxicological effects and bladder cancer biology, using an integrative multi-cohort computational framework. METHODS: Bioinformatics strategies were applied to assemble 9,591 putative molecular targets associated with perfluorooctanoic acid (PFOA) from five independent databases. Differential expression analysis and weighted gene co-expression network analysis were then conducted across five bladder cancer cohorts to delineate tumor-related genes. Functional enrichment analyses, machine learning-based modeling with SHAP interpretation, and molecular docking were subsequently employed to explore affected biological pathways and evaluate predictive performance. RESULTS: A total of 69 candidate genes, predominantly associated with cell cycle control and DNA damage-related processes, were delineated. From these, a nine-gene classifier yielded excellent discriminatory performance, achieving an AUC of 0.986 in the training set and maintaining robust accuracy across multiple external cohorts (AUCs: 0.944-1.000). SHAP-based interpretability analyses identified MCM7 as the most influential contributor to bladder cancer classification. In silico docking further suggested a strong predicted interaction between PFOA and IGFBP2, with a binding energy of -13.0 kcal/mol. CONCLUSION: By integrating toxicological target prediction with large-scale bladder cancer transcriptomic analyses, this study provides a computational bridge between environmental chemical exposure and cancer-related molecular programs. The resulting nine-gene classifier demonstrates strong and consistent performance across independent cohorts and captures transcriptional features that intersect with PFOA-associated toxicological pathways, offering a systems-level, hypothesis-generating perspective on transcriptional programs that overlap between predicted PFOA-associated targets and bladder cancer biology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oncology, Yantian District People's Hospital, Shenzhen, China.
- Science and Educational Center, Luohu Hospital Group, The Third Affiliated Hospital of Shenzhen University Shenzhen, Guangdong, China.
- Department of Urinary Surgery, Shenzhen Second People's Hospital, the First Affiliated Hospital of Shenzhen University, Shenzhen, Guangdong, China. wanghan2017@163.com.
Förderung
- the Medical and Health Science and Technology Program of Yantian District, Shenzhen
- the National Natural Science Foundation of China
Zitieren
APA
Liu, Y., Tang, A., & Wang, H. (2026). Toxicogenomic Characterization of Perfluorooctanoic Acid–Associated Bladder Carcinogenesis. Cell Biology and Toxicology. https://doi.org/10.1007/s10565-026-10164-5
Vancouver
Liu Y, Tang A, Wang H. Toxicogenomic Characterization of Perfluorooctanoic Acid–Associated Bladder Carcinogenesis. Cell Biology and Toxicology. 2026. doi:10.1007/s10565-026-10164-5
BibTeX
@article{Liu2026,
author = {Liu, Yang and Tang, Aifa and Wang, Han},
title = {Toxicogenomic Characterization of Perfluorooctanoic Acid–Associated Bladder Carcinogenesis},
journal = {Cell Biology and Toxicology},
year = {2026},
doi = {10.1007/s10565-026-10164-5}
}
EUVIMED